NAVEPEGRITIDE | N219164 | ASCENDIS PHARMA GROWTH DISORDERS AS
| Patent # | Expiration | PED | Drug Substance | Drug Product | Use Code | Delist |
|---|---|---|---|---|---|---|
| 8906847 | Apr 30, 2031 | — | Yes | Yes | U-4425 | — |
| 10835578 | Jan 5, 2037 | — | Yes | Yes | U-4425 | — |
| 11154593 | Jan 5, 2037 | — | Yes | Yes | U-4425 | — |
| 11224661 | Jan 5, 2037 | — | Yes | Yes | — | — |
| 11311604 | Jan 5, 2037 | — | Yes | Yes | U-4425 | — |
| 11389510 | Jan 5, 2037 | — | Yes | Yes | — | — |
| 11389511 | Jan 5, 2037 | — | — | Yes | U-4425 | — |
| 11413351 | Jan 5, 2037 | — | Yes | Yes | — | — |
| 12083182 | Jan 5, 2037 | — | — | — | U-4425 | — |
| 12156917 | Jan 5, 2037 | — | — | — | U-4425 | — |
| 12239689 | Jan 5, 2037 | — | — | — | U-4425 | — |
| 12377133 | Nov 12, 2042 | — | — | Yes | U-4425 | — |
| Code | Date | Status |
|---|---|---|
| NCE | Feb 27, 2031 | Active |
| ODE-516 | Feb 27, 2033 | Active |